Health Reform in the Balance: What It Means for Biopharma

The long road to enacting health reform appeared to be close to an end with final negotiations taking place in the White House. But the Senate race for Ted Kennedy's open seat in Massachusetts has put the bill, and pharma's hard-fought concessions, in the breach.

More from Archive

More from Pink Sheet